Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implanon: a critical review.

J Le1, C Tsourounis

  • 1School of Pharmacy, University of California at San Francisco, 94143-0622, USA.

The Annals of Pharmacotherapy
|March 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating a Tobacco-free Policy Intervention in Residential Substance Use Disorder Programs.

Journal of drug issues·2026
Same author

[Long-term hypomethylating agents in patients with myelodysplastic syndromes: a multi-center retrospective study].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024
Same author

High glucose inhibits the survival of HRMCs and its mechanism.

European review for medical and pharmacological sciences·2022
Same author

[Establishment of an auxiliary diagnosis system of newborn screening for inherited metabolic diseases based on artificial intelligence technology and a clinical trial].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2021
Same author

Corrigendum to: Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study.

QJM : monthly journal of the Association of Physicians·2021
Same author

Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study.

QJM : monthly journal of the Association of Physicians·2020
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
See all related articles

Implanon, a long-acting contraceptive implant, offers effective birth control for three years with minimal side effects. Fertility quickly returns after removal, making it a convenient long-term contraception option.

Area of Science:

  • Contraception and Family Planning
  • Reproductive Health
  • Pharmacology

Background:

  • Implanon is a novel single-rod contraceptive implant utilizing desogestrel.
  • It is designed for long-term, reversible contraception.

Purpose of the Study:

  • To assess the clinical efficacy of Implanon as a long-term contraceptive method.
  • To review the safety and adverse effect profile of Implanon.

Main Methods:

  • A comprehensive MEDLINE search (1966-1999) identified relevant human studies.
  • Pharmacokinetic, pharmacodynamic, and clinical trial data on desogestrel implants were reviewed.

Main Results:

  • Implanon inhibits ovulation within 24 hours, providing three years of effective contraception.

Related Experiment Videos

  • Fertility resumes within one month post-removal; insertion/removal procedures are simple with minor complications.
  • Common adverse effects include abnormal bleeding, weight gain, acne, breast pain, and headache.

    • Conclusions:

    • Implanon demonstrates high efficacy for long-term contraception with a favorable safety profile.
    • It represents a valuable addition to existing contraceptive choices.